Tolvaptan, (R)-

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C26H25ClN2O3
Molecular Weight	448.941
Optical Activity	( + )
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC1=CC=CC=C1C(=O)NC2=CC=C(C(=O)N3CCC[C@@H](O)C4=CC(Cl)=CC=C34)C(C)=C2

InChI

InChIKey=GYHCTFXIZSNGJT-XMMPIXPASA-N

InChI=1S/C26H25ClN2O3/c1-16-6-3-4-7-20(16)25(31)28-19-10-11-21(17(2)14-19)26(32)29-13-5-8-24(30)22-15-18(27)9-12-23(22)29/h3-4,6-7,9-12,14-15,24,30H,5,8,13H2,1-2H3,(H,28,31)/t24-/m1/s1

HIDE SMILES / InChI

Description

All pharmacological information is related to the racemic mixture, tolvaptan.

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Unknown 2596

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Unknown

Name

Type

Language

(R)-(+)-OPC-41061

Preferred Name

English

Tolvaptan, (R)-

Common Name

English

N-[4-[[(5R)-7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl]carbonyl]-3-methylphenyl]-2-methylbenzamide

Systematic Name

English

Benzamide, N-[4-[[(5R)-7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl]carbonyl]-3-methylphenyl]-2-methyl-

Systematic Name

English

Code System Code Type Description

EPA CompTox

DTXSID00332136

Created by admin on Mon Mar 31 23:20:21 GMT 2025 , Edited by admin on Mon Mar 31 23:20:21 GMT 2025

PRIMARY

FDA UNII

1E2497LPNY

Created by admin on Mon Mar 31 23:20:21 GMT 2025 , Edited by admin on Mon Mar 31 23:20:21 GMT 2025

PRIMARY

PUBCHEM

443894

Created by admin on Mon Mar 31 23:20:21 GMT 2025 , Edited by admin on Mon Mar 31 23:20:21 GMT 2025

PRIMARY

CAS

331947-66-1

Created by admin on Mon Mar 31 23:20:21 GMT 2025 , Edited by admin on Mon Mar 31 23:20:21 GMT 2025

PRIMARY

SUBSTANCE RECORD


					1E2497LPNY

Tolvaptan, (R)-